Enrolling by invitationPhase 4NCT07034859

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

Studying Non-functioning pituitary adenoma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Taiwan University Hospital
Intervention: Cabergoline 0.5 MG(drug)
Enrollment: 30 enrolled
Eligibility: 18 years · All sexes
Timeline: 2024 – 2028

Study locations (1)

National Taiwan University Hospital, Taipei, Taiwan, Taiwan

Collaborators

National Taiwan University Hospital Beihu Branch · National Taiwan University · National Taiwan University Hospital Hsin-Chu Branch · National Taiwan University Hospital, Yun-Lin Branch

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07034859 on ClinicalTrials.gov

← Back to all trials